
American Water's 2025 Second Quarter Conference Call Scheduled for July 31, 2025
John Griffith, President and Chief Executive Officer; David Bowler, Executive Vice President and Chief Financial Officer; and Cheryl Norton, Executive Vice President and Chief Operating Officer, will host a conference call and webcast with investors, analysts and other interested parties on Thursday, July 31, 2025, at 9 a.m. Eastern Time. There will be a question-and-answer session as part of the call.
Interested parties may listen to an audio webcast of the conference call through a link on the Investor Relations website at ir.amwater.com. Presentation slides that will be used in conjunction with the earnings conference call will also be made available online in advance at ir.amwater.com. A replay of the audio webcast will be available for one year on American Water's investor relations website at ir.amwater.com/events. The company recognizes its website as a key channel of distribution to reach public investors and as a means of disclosing material non-public information to comply with its obligations under SEC Regulation FD.
About American Water
American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to more than 14 million people with regulated operations in 14 states and on 18 military installations. American Water's 6,700 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders.
For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.
AWK-IR
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Jim Cramer on Royal Caribbean: 'Expectations Simply Got Too High'
Royal Caribbean Cruises Ltd. (NYSE:RCL) is one of the stocks Jim Cramer recently talked about. Cramer discussed the company's earnings and the market reaction to it during the episode. He said: 'Today's earnings made me feel like we'd forgotten the impact of all the tariff turmoil on the consumer. Some of the decline, I think, was an overreaction. Royal Caribbean went down on its outlook. But I gotta tell you, I checked that one out. I think the expectations simply got too high. People got used to this cruise line just crushing the high end of the estimates. Didn't happen.' Nonwarit/ Royal Caribbean (NYSE:RCL) is a cruise operator that provides diverse itineraries through multiple brands, including Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. In a March episode, Cramer mentioned the company and said: 'What else in travel's worth taking a look at?… It's tough for me to square the heinous action with what we just heard from Jason Liberty, the CEO of Royal Caribbean. When he came on the show last week, first, Liberty confirmed that its… consumers perceive Royal Caribbean cruises as a better value than a land-based vacation, reinforcing my view the cruise lines can still do fine even in a softer economy. Second, he cited its own bookings and on-ship spending data from recent voyages saying matter-of-factly, 'that cash register continues to ring and be consistent.' Since the above comment was made, Royal Caribbean (NYSE:RCL) stock is up over 61%. While we acknowledge the potential of RCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
3D Systems Announces Full Commercial Release of FDA-Cleared NextDent Jetted Denture Solution, Revolutionizes Digital Dentistry
3D Systems Corporation (NYSE:DDD) is one of the tech stocks to buy according to analysts. On July 29, 3D Systems announced the full commercial release of its FDA-cleared NextDent Jetted Denture Solution for the US market. The solution represents a milestone in digital dentistry by enabling the production of multi-material and monolithic (one-piece) jetted dentures using a single printing process. The method results in a faster, more cost-effective, and highly scalable alternative to traditional denture fabrication. The core of this solution is the new NextDent 300 MultiJet 3D printer, which enables the rapid production of patient-specific dentures that are fully cured and safe to handle immediately, eliminating the need for additional post-curing steps. A closeup of a modern 3D printer, showing the intricate detail it can produce. To complement the printer, 3D Systems' materials scientists developed two FDA-cleared dental materials: NextDent Jet Teeth and NextDent Jet Base. When used together with the NextDent 300 printer, these materials provide desired tooth rigidity, gum support, outstanding aesthetics, and enhanced toughness. 3D Systems Corporation (NYSE:DDD) provides 3D printing and digital manufacturing solutions in North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. It operates through 2 segments: Healthcare Solutions and Industrial Solutions. While we acknowledge the potential of DDD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Jim Cramer on Merck's Latest Quarterly Report: 'I Actually Liked It'
Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently talked about. Cramer mentioned the stock and said that he liked its quarter. He remarked: 'What do we make of the numbers that we got from Merck this morning? The pharma titan reported what some thought was a mixed quarter. I actually liked it. Small revenue miss, paired with an 11-cent earnings beat. Stock got hit, finishing the day down nearly 2% although it was a lot lower at one point. Photo by Nicholas Cappello on Unsplash Merck (NYSE:MRK) develops and sells pharmaceuticals for human and animal health, covering areas such as oncology, vaccines, virology, and livestock care. The company also holds multiple collaboration and licensing agreements to advance treatments across various medical conditions. While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio